SMARCA4 c.2462A>G ;(p.E821G)

Variant ID: 19-11129656-A-G

NM_003072.3(SMARCA4):c.2462A>G;(p.E821G)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI.

Frontiers In Oncology
Deng, Haiyi H; Lin, Xinqing X; Xie, Xiaohong X; Yang, Yilin Y; Wang, Liqiang L; Wu, Jianhui J; Liu, Ming M; Xie, Zhanhong Z; Qin, Yinyin Y; Zhou, Chengzhi C
Publication Date: 2021

Variant appearance in text: SMARCA4: E821G
PubMed Link: 34616674
Variant Present in the following documents:
  • DataSheet_1.pdf
View BVdb publication page



Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients.

Nature Communications
Fernando, Tharu M TM; Piskol, Robert R; Bainer, Russell R; Sokol, Ethan S ES; Trabucco, Sally E SE; Zhang, Qing Q; Trinh, Huong H; Maund, Sophia S; Kschonsak, Marc M; Chaudhuri, Subhra S; Modrusan, Zora Z; Januario, Thomas T; Yauch, Robert L RL
Publication Date: 2020-11-03

Variant appearance in text: SMARCA4: E821G
PubMed Link: 33144586
Variant Present in the following documents:
  • 41467_2020_19402_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page